SPECTRAL AI INC.

NASDAQ: MDAI (Spectral AI, Inc.)

Last update: 3 days ago, 2:37PM

3.01

0.26 (9.27%)

Previous Close 2.75
Open 3.05
Volume 4,804,743
Avg. Volume (3M) 2,130,124
Market Cap 62,364,872
Price / Sales 1.17
52 Weeks Range
0.824 (-72%) — 3.72 (23%)
Earnings Date 25 Mar 2025 - 31 Mar 2025
Profit Margin -40.78%
Operating Margin (TTM) -10.84%
Diluted EPS (TTM) -0.630
Quarterly Revenue Growth (YOY) 137.60%
Current Ratio (MRQ) 0.730
Operating Cash Flow (TTM) -12.04 M
Levered Free Cash Flow (TTM) -7.45 M
Return on Assets (TTM) -43.87%
Return on Equity (TTM) -2,308.32%

Market Trend

Short Term Medium Term
Industry Medical Devices (US) Mixed Mixed
Medical Devices (Global) Mixed Mixed
Stock Spectral AI, Inc. Mixed -

AIStockmoo Score

-1.3
Analyst Consensus NA
Insider Activity NA
Price Volatility -5.0
Technical Moving Averages -1.0
Technical Oscillators 2.0
Average -1.33

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
MDAI 62 M - - -
CBLL 925 M - - -
DHAI 84 M - - 3.03
BDMD 63 M - 5.05 0.960
ADGM 24 M - - 0.180
QTI 9 M - - -

Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient’s wound.

Sector Healthcare
Industry Medical Devices
% Held by Insiders 44.27%
% Held by Institutions 21.77%

Ownership

Name Date Shares Held
Highlander Partners, L.P. 30 Sep 2024 900,000
Rathbones Group Plc 30 Sep 2024 436,122
University Of Texas/Texas Am Investment Management Co 30 Sep 2024 210,488
Hsbc Holdings Plc 30 Sep 2024 81,285
Forum Financial Management, Lp 30 Sep 2024 29,098

No data within this time range.

No data within this time range.

Date Type Details
31 Dec 2024 Announcement Spectral AI Provides Instructions for Retail Investors on Exercising Publicly-Traded Warrants
23 Dec 2024 Announcement Spectral AI Announces Confirmation of Compliance of its Nasdaq Listing Requirements
13 Dec 2024 Announcement Spectral AI Comments on Compliance with Nasdaq Listing Rule 5550(b)(2)
12 Dec 2024 Announcement Spectral AI Highlights Unprecedented Collaboration with National Leaders in Burn Care for DeepView™ System Training and Validation Studies
09 Dec 2024 Announcement Spectral AI Incorporates Frontline Feedback into Improved Software Release for Enhanced Diagnostic Precision
02 Dec 2024 Announcement Spectral AI Completes Truthing of Burn Center Images, Initiates Emergency Department Image Review
26 Nov 2024 Announcement Spectral AI Announces Repricing of its Public Warrants
21 Nov 2024 Announcement Spectral AI Announces DeepView SnapShot® M Moves Forward with Feedback from Brooke Army Medical Center Institute of Surgical Research
19 Nov 2024 Announcement Spectral AI Raises Up to $5 Million Financing Strengthening Financial Position for FDA Pathway
06 Nov 2024 Announcement Spectral AI Announces Plan to Spin Off Spectral IP Subsidiary Focused on Intellectual Property Investments and Monetization
06 Nov 2024 Announcement Spectral AI Announces 2024 Third Quarter Financial Results
30 Oct 2024 Announcement Spectral AI Announces Last Patient Out in U.S. Burn Pivotal Study at Burn Centers
23 Oct 2024 Announcement Spectral AI Schedules 2024 Third Quarter Financial Results and Conference Call
14 Oct 2024 Announcement Spectral AI, Inc. Announces Return of Founder Dr. J. Michael DiMaio as Chairman of the Board of Directors
03 Oct 2024 Announcement Spectral AI Completes Proof of Concept for Wound Measurement Technology
Show more

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2025 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria